WHITE PAPER
Increase Efficiency and Reduce Risk with a Molecule-to-Market Action Plan
Explore an illustrative drug sponsor case study of the mechanisms of end-to-end regulatory engagement.
May 22, 2023

Bringing your drug from molecule to market necessitates expert navigation of the clinical development landscape and its accompanying regulatory systems.

IQVIA's Regulatory Affairs and Drug Development Solutions (RADDS) group assists companies — emerging biotechs to pharmaceutical giants — with their clinical development and regulatory processes, from the discovery phase through to commercial availability. RADDS equips your team with highly skilled resources and a bespoke outsourcing model designed to drive existing organizational efficiencies. Throughout the process, IQVIA staff provide extensive support, including regulatory intelligence, investigational new drug (IND) and marketed product (NDA/BLA/MAA) application strategies, early- and late-stage gap analyses, market expansion, lifecycle management, regulatory operations, and technology access.

For a glimpse inside the mechanisms of end- to-end regulatory engagement, explore an illustrative case study of IQVIA customer, ABC Therapeutics.

Related solutions

Contact Us